Patheon Softgels

Patheon Softgels is a specialized business unit within Thermo Fisher Scientific that provides contract development and manufacturing services for softgel dosage forms. The division was significantly bolstered by the 2012 acquisition of Banner Pharmacaps, establishing it as a global leader in softgel technology and innovation. They offer a wide range of proprietary delivery platforms, including Liqui-Soft for improved solubility and Vegicaps for animal-free encapsulation. Patheon Softgels supports the entire product lifecycle, from initial formulation and clinical trial material production to large-scale commercial manufacturing. With facilities in North America and Europe, they serve a diverse client base across the pharmaceutical, over-the-counter, and nutritional industries. Their expertise is particularly focused on solving complex bioavailability challenges and providing patient-centric dosage solutions.